Comments
Loading...
Immunocore Holdings Analyst Ratings and Price Targets | NASDAQ:IMCR | Benzinga
Immunocore Holdings PLC has a consensus price target of $69.76 based on the ratings of 19 analysts. The high is $100 issued by HC Wainwright & Co. on March 12, 2025. The low is $24 issued by UBS on October 24, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Needham, and Mizuho on April 14, 2025, April 10, 2025, and April 7, 2025, respectively. With an average price target of $51.33 between JP Morgan, Needham, and Mizuho, there's an implied 71.25% upside for Immunocore Holdings PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Needham
Mizuho
HC Wainwright & Co.
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Immunocore Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/14/2025 | Buy Now | 66.81% | JP Morgan | Jessica Fye64% | $54 → $50 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 136.86% | Needham | Gil Blum51% | $71 → $71 | Reiterates | Buy → Buy | Get Alert |
| 04/07/2025 | Buy Now | 10.09% | Mizuho | Graig Suvannavejh50% | $38 → $33 | Maintains | Neutral | Get Alert |
| 03/12/2025 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | Buy Now | 136.86% | Needham | Gil Blum51% | $71 → $71 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | Buy Now | 16.76% | Morgan Stanley | Andrew Galler33% | $35 → $35 | Assumes | → Equal-Weight | Get Alert |
| 03/05/2025 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | 136.86% | Needham | Gil Blum51% | $71 → $71 | Reiterates | Buy → Buy | Get Alert |
| 01/27/2025 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | 136.86% | Needham | Gil Blum51% | $71 → $71 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2024 | Buy Now | 16.76% | Morgan Stanley | Andrew Galler33% | $74 → $35 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/11/2024 | Buy Now | 26.77% | Mizuho | Graig Suvannavejh50% | $72 → $38 | Downgrade | Outperform → Neutral | Get Alert |
| 11/07/2024 | Buy Now | 136.86% | Needham | Gil Blum51% | $78 → $71 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -19.93% | UBS | David Dai26% | → $24 | Initiates | → Sell | Get Alert |
| 10/24/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | 146.87% | Morgan Stanley | Andrew Galler33% | $80 → $74 | Maintains | Overweight | Get Alert |
| 10/07/2024 | Buy Now | — | Guggenheim | Michael Schmidt54% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/17/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 09/17/2024 | Buy Now | 160.22% | Needham | Gil Blum51% | $81 → $78 | Maintains | Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Eric Schmidt32% | — | Reiterates | → Overweight | Get Alert |
| 08/28/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | 196.91% | Oppenheimer | Jeff Jones33% | $87 → $89 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2024 | Buy Now | 120.18% | Barclays | Peter Lawson41% | $92 → $66 | Maintains | Overweight | Get Alert |
| 08/09/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2024 | Buy Now | 120.18% | JP Morgan | Jessica Fye64% | $70 → $66 | Maintains | Overweight | Get Alert |
| 06/05/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 05/29/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 193.58% | Mizuho | Graig Suvannavejh50% | $90 → $88 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 123.52% | Canaccord Genuity | Bill Maughan19% | $63 → $67 | Maintains | Hold | Get Alert |
| 05/09/2024 | Buy Now | 233.61% | HC Wainwright & Co. | Patrick Trucchio44% | $90 → $100 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | → $81 | Reiterates | Buy → Buy | Get Alert |
| 04/29/2024 | Buy Now | 146.87% | Leerink Partners | Jonathan Chang39% | → $74 | Initiates | → Outperform | Get Alert |
| 04/23/2024 | Buy Now | 206.92% | Guggenheim | Michael Schmidt54% | $92 → $92 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | 133.53% | JP Morgan | Jessica Fye64% | $60 → $70 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | Buy Now | 200.25% | Mizuho | Graig Suvannavejh50% | $86 → $90 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 190.24% | Oppenheimer | Justin Kim37% | $85 → $87 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | Buy Now | 110.18% | Canaccord Genuity | Bill Maughan19% | $60 → $63 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 170.23% | Needham | Gil Blum51% | → $81 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | Buy Now | 186.91% | Mizuho | Graig Suvannavejh50% | $72 → $86 | Maintains | Buy | Get Alert |
| 11/20/2023 | Buy Now | 100.17% | JP Morgan | Jessica Fye64% | → $60 | Reinstates | → Overweight | Get Alert |
| 11/02/2023 | Buy Now | — | Cantor Fitzgerald | Eric Schmidt32% | — | Initiates | → Overweight | Get Alert |
| 10/31/2023 | Buy Now | 180.23% | Baird | Jack Allen 35% | → $84 | Initiates | → Outperform | Get Alert |
| 09/21/2023 | Buy Now | 183.57% | Oppenheimer | Justin Kim37% | $75 → $85 | Maintains | Outperform | Get Alert |
| 09/13/2023 | Buy Now | 150.21% | Needham | Gil Blum51% | → $75 | Initiates | → Buy | Get Alert |
| 08/23/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | Buy Now | 180.23% | Capital One | Naureen Quibria19% | → $84 | Initiates | → Overweight | Get Alert |
| 08/11/2023 | Buy Now | 203.59% | BTIG | Justin Zelin41% | $85 → $91 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 150.21% | Oppenheimer | Justin Kim37% | $72 → $75 | Maintains | Outperform | Get Alert |
| 08/11/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/31/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 123.52% | Canaccord Genuity | Bill Maughan19% | → $67 | Initiates | → Hold | Get Alert |
| 07/11/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | Buy Now | 163.55% | Goldman Sachs | Rajan Sharma25% | → $79 | Reiterates | → Overweight | Get Alert |
| 06/12/2023 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | → $79 | Reiterates | → Overweight | Get Alert |
| 05/12/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 146.87% | Mizuho | Graig Suvannavejh50% | $70 → $74 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 133.53% | Mizuho | Graig Suvannavejh50% | → $70 | Initiates | → Buy | Get Alert |
| 03/30/2023 | Buy Now | 183.57% | Guggenheim | Michael Schmidt54% | → $85 | Initiates | → Buy | Get Alert |
| 03/08/2023 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | → $90 | Reiterates | → Buy | Get Alert |
| 02/15/2023 | Buy Now | 140.2% | Oppenheimer | Justin Kim37% | $65 → $72 | Maintains | Outperform | Get Alert |
| 12/16/2022 | Buy Now | — | Goldman Sachs | Rajan Sharma25% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/30/2022 | Buy Now | 166.89% | Barclays | Peter Lawson41% | → $80 | Initiates | → Overweight | Get Alert |
| 11/21/2022 | Buy Now | 200.25% | HC Wainwright & Co. | Patrick Trucchio44% | $80 → $90 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | 163.55% | Morgan Stanley | Andrew Galler33% | $72 → $79 | Maintains | Overweight | Get Alert |
| 10/13/2022 | Buy Now | 140.2% | Morgan Stanley | Andrew Galler33% | $77 → $72 | Maintains | Overweight | Get Alert |
| 09/14/2022 | Buy Now | 123.52% | JP Morgan | Jessica Fye64% | $60 → $67 | Maintains | Overweight | Get Alert |
| 09/09/2022 | Buy Now | 156.88% | Morgan Stanley | Andrew Galler33% | → $77 | Initiates | → Overweight | Get Alert |
| 09/08/2022 | Buy Now | 173.56% | Ladenburg Thalmann | Ahu Demir18% | → $82 | Initiates | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 133.53% | Cowen & Co. | Tyler Van Buren46% | → $70 | Initiates | → Outperform | Get Alert |
| 08/02/2022 | Buy Now | 183.57% | BTIG | Justin Zelin41% | → $85 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Immunocore Holdings (IMCR) stock?
The latest price target for Immunocore Holdings (NASDAQ:IMCR) was reported by JP Morgan on April 14, 2025. The analyst firm set a price target for $50.00 expecting IMCR to rise to within 12 months (a possible 66.81% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Immunocore Holdings (IMCR)?
The latest analyst rating for Immunocore Holdings (NASDAQ:IMCR) was provided by JP Morgan, and Immunocore Holdings maintained their overweight rating.
When was the last upgrade for Immunocore Holdings (IMCR)?
The last upgrade for Immunocore Holdings PLC happened on December 16, 2022 when Goldman Sachs raised their price target to N/A. Goldman Sachs previously had a neutral for Immunocore Holdings PLC.
When was the last downgrade for Immunocore Holdings (IMCR)?
The last downgrade for Immunocore Holdings PLC happened on December 13, 2024 when Morgan Stanley changed their price target from $74 to $35 for Immunocore Holdings PLC.
When is the next analyst rating going to be posted or updated for Immunocore Holdings (IMCR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immunocore Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immunocore Holdings was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
Is the Analyst Rating Immunocore Holdings (IMCR) correct?
While ratings are subjective and will change, the latest Immunocore Holdings (IMCR) rating was a maintained with a price target of $54.00 to $50.00. The current price Immunocore Holdings (IMCR) is trading at is $29.98, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
